RecruitingPhase 1NCT07324954

Methylene Blue in Total Knee Arthroplasty (TKA)

Impact of Irrigation Volumes in Revision Total Knee Arthroplasty (TKA) Surgical Washout: A Pilot Study


Sponsor

University of Miami

Enrollment

20 participants

Start Date

Feb 4, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this pilot study is to determine the volume of irrigation required to achieve macroscopic clearance of contaminants during a debridement, antibiotics, and implant retention (DAIR) procedure for periprosthetic joint infection (PJI) of the knee. Given the lack of robust data guiding irrigation volume in this setting, the investigator proposes to use the application of methylene blue dye intraoperatively to simulate contaminant presence. Serial irrigation will be performed, with photographic documentation taken every 2,000mL until visible dye clearance is achieved. This study aims to identify the irrigation volumes that result in gross clearance of simulated contamination, thereby informing the design and stratification of a future randomized controlled trial (RCT) evaluating irrigation strategies in DAIR procedures.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Primary Total Knee Arthroplasty (TKA) or Primary Total Knee Arthroplasty (TKA) with Prosthetic Joint Infection (PJI)
  • years
  • Able to provide informed consent

Exclusion Criteria10

  • Incomplete irrigation documentation
  • Patients with severe immunosuppression (example: chemotherapy, neutropenia, Human Immunodeficiency Virus \[HIV\], steroid use)
  • Positive fungal, parasitic, or mycobacterial cultures
  • Methylene Blue allergy
  • Patients on Monoamine Oxidase (MAO) inhibitors, Selective Serotonin Reuptake Inhibitors (SSRI), Selective Norepinephrine Reuptake Inhibitors (SNRI), and/or Tricyclic Antidepressants (TCA)
  • History of methemoglobinemia
  • Glucose-6-Phosphate (G6P) Enzyme Deficiency
  • Chronic Kidney disease or Glomerular Filtration Rate (GFR) less than 30mL/min
  • Prisoners
  • Pregnant Woman

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethylene Blue 10 MG/ML (intra-articular application)

10 mL of 0.25% methylene blue dissolved in 20 mL normal saline, applied intra-articularly via sterile gauze to simulate contaminant presence. Irrigation performed in 2,000 mL increments until macroscopic dye clearance is achieved. Used solely as a surrogate marker; no therapeutic intent

PROCEDURERevision Arthroplasty for PJI (DAIR)

Standard of care surgical procedure performed for documented periprosthetic joint infection

PROCEDUREPrimary Total Knee Arthroplasty

Standard of care surgical procedure performed for severe knee osteoarthritis


Locations(1)

UHealth Tower

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07324954


Related Trials